The potential danger of suboptimal antibody responses in COVID-19

There is a desperate need for effective therapies and vaccines for SARS-CoV-2 to mitigate the growing economic crisis that has ensued from societal lockdown. Vaccines are being developed at an unprecedented speed and are already in clinical trials, without preclinical testing for safety and efficacy...

Descripción completa

Detalles Bibliográficos
Autores principales: Iwasaki, Akiko, Yang, Yexin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Comment
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7187142/
https://www.ncbi.nlm.nih.gov/pubmed/32317716
http://dx.doi.org/10.1038/s41577-020-0321-6
_version_ 1783527110583779328
author Iwasaki, Akiko
Yang, Yexin
author_facet Iwasaki, Akiko
Yang, Yexin
author_sort Iwasaki, Akiko
collection PubMed
description There is a desperate need for effective therapies and vaccines for SARS-CoV-2 to mitigate the growing economic crisis that has ensued from societal lockdown. Vaccines are being developed at an unprecedented speed and are already in clinical trials, without preclinical testing for safety and efficacy. Yet, safety evaluation of candidate vaccines must not be overlooked.
format Online
Article
Text
id pubmed-7187142
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-71871422020-04-28 The potential danger of suboptimal antibody responses in COVID-19 Iwasaki, Akiko Yang, Yexin Nat Rev Immunol Comment There is a desperate need for effective therapies and vaccines for SARS-CoV-2 to mitigate the growing economic crisis that has ensued from societal lockdown. Vaccines are being developed at an unprecedented speed and are already in clinical trials, without preclinical testing for safety and efficacy. Yet, safety evaluation of candidate vaccines must not be overlooked. Nature Publishing Group UK 2020-04-21 2020 /pmc/articles/PMC7187142/ /pubmed/32317716 http://dx.doi.org/10.1038/s41577-020-0321-6 Text en © Springer Nature Limited 2020 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Comment
Iwasaki, Akiko
Yang, Yexin
The potential danger of suboptimal antibody responses in COVID-19
title The potential danger of suboptimal antibody responses in COVID-19
title_full The potential danger of suboptimal antibody responses in COVID-19
title_fullStr The potential danger of suboptimal antibody responses in COVID-19
title_full_unstemmed The potential danger of suboptimal antibody responses in COVID-19
title_short The potential danger of suboptimal antibody responses in COVID-19
title_sort potential danger of suboptimal antibody responses in covid-19
topic Comment
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7187142/
https://www.ncbi.nlm.nih.gov/pubmed/32317716
http://dx.doi.org/10.1038/s41577-020-0321-6
work_keys_str_mv AT iwasakiakiko thepotentialdangerofsuboptimalantibodyresponsesincovid19
AT yangyexin thepotentialdangerofsuboptimalantibodyresponsesincovid19
AT iwasakiakiko potentialdangerofsuboptimalantibodyresponsesincovid19
AT yangyexin potentialdangerofsuboptimalantibodyresponsesincovid19

Ejemplares similares